Skip to content

Disease, drug, and structure source integration

This workflow illustrates retrieval across public databases, not a new therapeutic or mechanistic conclusion by Topologica.

An MCP client can request:

  1. map_disease_drug_landscape with a source-checked MONDO identifier to retrieve Open Targets and ChEMBL disease-drug records.
  2. assess_target_druggability with a source-checked UniProt accession to retrieve target evidence and an explicitly heuristic local summary.
  3. analyze_structural_confidence with the same source-checked accession to inspect AlphaFold DB predicted coordinates and confidence information.

Gene products, drug indications, structural models, and disease records are different evidence objects. A drug's reported indication does not show that the isolated AlphaFold structure represents a fusion protein, mutation, binding state, or treatment response.

Use source identifiers and provenance for any downstream scientific work. The earlier June 2026 numerical transcript is historical, not a maintained assertion about current source data or clinical actionability.